Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AbbVie Inc.
Report date February 28, 2017 · Filed March 02, 2017
Section 16 reporting ended · disclosed 2017-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, $0.01 par valueSEC Table I · non-derivative | Direct | 62,329 |
Ending reported balance
After 2017-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-02-28 · Sale · Disposed 200 · Balance 69,387 Row 2 · 2017-02-28 · Sale · Disposed 1,911 · Balance 67,476 Row 3 · 2017-02-28 · Sale · Disposed 200 · Balance 67,276 Row 4 · 2017-02-28 · Tax withholding · Disposed 4,947 · Balance 62,329 |
| Common stock, $0.01 par valueSEC Table I · non-derivative | IndirectProfit sharing trust | 447 |
Reported balance
Holding disclosure · report date 2017-02-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 447 F1: Balance in the AbbVie Savings Program as of February 28, 2017. |
| Common stock, $0.01 par valueSEC Table I · non-derivative | IndirectBy spouse in IRA | 274 |
Reported balance
Holding disclosure · report date 2017-02-28 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 274 F2: The reporting person disclaims beneficial ownership of all securities held by his spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the AbbVie Savings Program as of February 28, 2017.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 3,793 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 10 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 3,793 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 1,465 | $0.00 Strike: $27.15 | $0.00 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · derivative · entry 9 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,465 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 9,138 | $44.93 | $410,570.34 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · nonDerivative · entry 6 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,783 Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 191 | $29.40 | $5,615.99 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · nonDerivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 5,351 | $27.63 | $147,828.87 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · nonDerivative · entry 4 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 703 | $27.93 | $19,636.83 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · nonDerivative · entry 3 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 3,793 | $27.37 | $103,821.62 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2013 Filed Aug 16, 2013 21:06 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 1,465 | $27.15 | $39,780.17 |
DisclosureSEC source: 0001179110-13-013243 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2013 Filed Mar 4, 2013 22:08 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 2,191 | $36.73 | $80,475.43 |
DisclosureSEC source: 0001179110-13-004013 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,418 Read SEC document |
| February 19, 2013 Filed Feb 20, 2013 00:05 UTC | AbbVie Inc. ABBV · Entity 2800 | Tax withholdingCommon stock, $0.01 par value | 2,265 | $37.58 | $85,118.70 |
DisclosureSEC source: 0001179110-13-003028 · edgar.xml · nonDerivative · entry 2 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,609 Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantOption (right to buy) · Derivative | 35,620 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-13-003028 · edgar.xml · derivative · entry 5 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,620 Underlying: Common stock · 35,620 shares Expires 2023-02-13 F4 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 11,874 on 02/14/2014, 11,873 on 02/14/2015, and 11,873 on 02/14/2016. Read SEC document |
| February 14, 2013 Filed Feb 20, 2013 00:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon stock, $0.01 par value | 17,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003028 · edgar.xml · nonDerivative · entry 1 HURWICH THOMAS A. · CIK 0001563573 · VP, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,874 F1 · shares: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.